Klaus Seppi

Research interests

Publications

• Trial of Deferiprone in Parkinson’s Disease

  New England Journal of Medicine · 2022 · https://doi.org/10.1056/nejmoa2209254

• European Academy of Neurology/Movement Disorder Society‐European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies

  Movement Disorders · 2022 · https://doi.org/10.1002/mds.29066

• The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy

  Movement Disorders · 2022 · https://doi.org/10.1002/mds.29005

• Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review

  Movement Disorders · 2019 · https://doi.org/10.1002/mds.27602

• Validation of the MDS clinical diagnostic criteria for Parkinson's disease

  Movement Disorders · 2018 · https://doi.org/10.1002/mds.27362

• Differences in MDS ‐ UPDRS Scores Based on Hoehn and Yahr Stage and Disease Duration

  Movement Disorders Clinical Practice · 2017 · https://doi.org/10.1002/mdc3.12476

• Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria

  Movement Disorders · 2017 · https://doi.org/10.1002/mds.26987

• Parkinson disease

  Nature Reviews Disease Primers · 2017 · https://doi.org/10.1038/nrdp.2017.13

• Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder

  Annals of Neurology · 2017 · https://doi.org/10.1002/ana.25026

• The O nset of N onmotor S ymptoms in P arkinson's disease ( T he ONSET PD S tudy)

  Movement Disorders · 2014 · https://doi.org/10.1002/mds.26077

• The natural history of multiple system atrophy: a prospective European cohort study

  The Lancet Neurology · 2013 · https://doi.org/10.1016/s1474-4422(12)70327-7

• Prevalence and Burden of Gait Disorders in Elderly Men and Women Aged 60–97 Years: A Population-Based Study

  PLoS ONE · 2013 · https://doi.org/10.1371/journal.pone.0069627

• A Mutation in VPS35, Encoding a Subunit of the Retromer Complex, Causes Late-Onset Parkinson Disease

  The American Journal of Human Genetics · 2011 · https://doi.org/10.1016/j.ajhg.2011.06.008

• The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease

  Movement Disorders · 2011 · https://doi.org/10.1002/mds.23884

• White and gray matter abnormalities in idiopathic rapid eye movement sleep behavior disorder: A diffusion‐tensor imaging and voxel‐based morphometry study

  Annals of Neurology · 2010 · https://doi.org/10.1002/ana.22245

• Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study

  The Lancet Neurology · 2010 · https://doi.org/10.1016/s1474-4422(10)70216-7

• Presentation, diagnosis, and management of multiple system atrophy in Europe: Final analysis of the European multiple system atrophy registry

  Movement Disorders · 2010 · https://doi.org/10.1002/mds.23192

• Red flags for multiple system atrophy

  Movement Disorders · 2008 · https://doi.org/10.1002/mds.21992

• Second consensus statement on the diagnosis of multiple system atrophy

  Neurology · 2008 · https://doi.org/10.1212/01.wnl.0000324625.00404.15

• Restless legs syndrome

  Neurology · 2005 · https://doi.org/10.1212/01.wnl.0000163996.64461.a3

• Grading of neuropathology in multiple system atrophy: Proposal for a novel scale

  Movement Disorders · 2005 · https://doi.org/10.1002/mds.20537

• Prevalence of movement disorders in men and women aged 50–89 years (Bruneck Study cohort): a population-based study

  The Lancet Neurology · 2005 · https://doi.org/10.1016/s1474-4422(05)70226-x

• Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS)

  Movement Disorders · 2004 · 10.1002/mds.20255

• Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease

  Journal of Neural Transmission · 2002 · https://doi.org/10.1007/s007020200027

• Modafinil for the Treatment of Daytime Sleepiness in Parkinson´s Disease: A Double-blind, Randomized, Crossover, Placebo-controlled Polygraphic Trial

  SLEEP · 2002 · https://doi.org/10.1093/sleep/25.8.62

Current projects

No projects listed.